DS Davies
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 15
- Pharmacogenetics and Drug Metabolism 14
- Plant-based Medicinal Research 3
-
- Metabolism and Genetic Disorders 3
- Co-authors
- Alan R. BoobisSandra MurrayDorothea SesardicMJ BrodieGC KahnC KahnD. Nicholas BatemanRafael de la Torre
- Journals
- British Journal of Clinical Pharmacology (21 papers)Life Sciences (1 paper)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (10 papers)
- Partner nations
- United KingdomNorway
In The Last Decade
DS Davies
32 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 100
- Pharmacology 827
- Biochemistry 108
- Oncology 384
- Clinical Biochemistry 93
- Pharmaceutical Science 62
Countries citing papers authored by DS Davies
This map shows the geographic impact of DS Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DS Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DS Davies more than expected).
Fields of papers citing papers by DS Davies
This network shows the impact of papers produced by DS Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DS Davies. The network helps show where DS Davies may publish in the future.
Co-authorship network
The 25 scholars most cited alongside DS Davies, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Systemic exposure to dietary heterocyclic amines in man. | 1995 | 6 |
| 2 | Exposure to, and activation of, the food derived mutagenic heterocyclic amine MeIQx. | 1990 | 1 |
| 3 | 1990 | 246 | |
| 4 | An introduction to metabolic and kinetic aspects of toxicological studies. | 1988 | 4 |
| 5 | 1986 | 21 | |
| 6 | 1985 | 31 | |
| 7 | Pharmacokinetic studies with inhaled drugs. | 1982 | 12 |
| 8 | Metabolism and mutagenic activation of 2-acetylaminofluorene by human liver and lung. | 1981 | 9 |
| 9 | 1980 | 74 | |
| 10 | 1980 | 24 | |
| 11 | 1980 | 136 | |
| 12 | 1980 | 14 | |
| 13 | 1979 | 39 | |
| 14 | 1978 | 69 | |
| 15 | 1978 | 3 | |
| 16 | Phenylbutazone: factors influencing plasma concentrations. | 1977 | 2 |
| 17 | 1977 | 17 | |
| 18 | 1977 | 4 | |
| 19 | 1976 | 57 | |
| 20 | Induction of drug metabolizing enzymes in man and rat by dichloralphenazone. | 1969 | 5 |
About DS Davies
DS Davies is a scholar working on Pharmacology, Clinical Biochemistry, Biochemistry, Oncology and Animal Science and Zoology, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (5 papers), Nausea and vomiting management (4 papers), Cancer Treatment and Pharmacology (4 papers), Metabolism and Genetic Disorders (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Cardiovascular Syncope and Autonomic Disorders (3 papers) and Plant-based Medicinal Research (3 papers). The work is most often cited by research in Pharmacology (827 citations), Biochemistry (108 citations), Oncology (384 citations), Clinical Biochemistry (93 citations) and Pharmaceutical Science (62 citations). DS Davies has collaborated with scholars based in United Kingdom and Norway. Frequent co-authors include Alan R. Boobis, Sandra Murray, Dorothea Sesardic, MJ Brodie, GC Kahn, C Kahn, D. Nicholas Bateman, Rafael de la Torre, Jordi Segura and Κ. Mashiter. Their work appears in journals such as British Journal of Clinical Pharmacology, Life Sciences, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.